论文部分内容阅读
迅速而有效地抗菌治疗,是提高婴幼儿脑膜炎的存活率,降低病死率的主要措施。但由于一些常用的抗生素药物的血——脑脊液(CSF)渗透率较低,或出现新的耐药菌株等,给细菌性脑膜炎的治疗带来困难。近几年来,通过临床抗生素的筛选和疗效评价,使婴幼儿细菌性脑膜炎的抗菌治疗获得进展。一、婴幼儿脑膜炎的抗菌治疗现状细菌性脑膜炎常见的病原菌为脑膜炎球菌、肺炎球菌和流感嗜血杆菌等。在婴幼儿
Rapid and effective antibacterial treatment is to improve the survival rate of infant meningitis, reduce the mortality of the main measures. However, the treatment of bacterial meningitis is difficult due to the low blood-cerebrospinal fluid (CSF) permeability of some commonly used antibiotic drugs, or the emergence of new drug-resistant strains. In recent years, clinical antibiotic screening and evaluation of the efficacy of antibacterial treatment of bacterial meningitis in infants and young children progress. First, the status of anti-bacterial treatment of infant meningitis Bacterial meningitis common pathogens are meningococci, pneumococcal and Haemophilus influenzae and so on. In infants and young children